MDT — Medtronic

Profile

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

Employees: 95,000 · Website: https://www.medtronic.com · Profile fields populated: 75%

Data completeness by statement

Share of stored fields populated in the anchor reporting period (FY2026), primary source sec_edgar. Full per-field breakdown: GET /api/v1/companies/MDT/financials.

Financial statement coverage (USD)

Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.

Get MDT data via the API

Every number on this page is one API call away. Free API keys — no card required.

Other NYSE · Health Care companies covered

Frequently Asked Questions

What data does the API provide for MDT?

Company profile, financial statements, computed ratios, price data, filings and news for MDT, via REST endpoints under /api/v1/companies/MDT. Every financial field carries a source tag for provenance.

How complete is MDT's financial data?

The anchor reporting period (FY2026) has 100.0% of the 17 core statement fields populated. Primary source: sec_edgar.

What reporting periods are covered for MDT?

5 fiscal-year periods are stored (FY2022–FY2026), with per-period field counts and source tags available via /api/v1/companies/MDT/financials.

Where does MDT's data come from?

Primary source for the latest statements: sec_edgar. The API records a source tag on every field and exposes them via /api/v1/companies/MDT/financials, so each value is traceable.